Back to Search
Start Over
Brentuximab Vedotin and AVD Chemotherapy Followed by ISRT: A Safe Primary Treatment Regimen for Early-Stage, Unfavorable Hodgkin Lymphoma.
- Source :
-
International Journal of Radiation Oncology, Biology, Physics . Oct2016 Supplement, Vol. 96, pS21-S21. 1p. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 03603016
- Volume :
- 96
- Database :
- Academic Search Index
- Journal :
- International Journal of Radiation Oncology, Biology, Physics
- Publication Type :
- Academic Journal
- Accession number :
- 117553627
- Full Text :
- https://doi.org/10.1016/j.ijrobp.2016.06.064